Rejected at 10:21 p.m. Oct, 28, 2023 ] by Ahmed7
Author: shmuelsash
Related Note: 1477447024779 2
Rationale for change

UW2 QID - most common wrong answer (34%)

48% chose correct answer

Rejection reason

comments

Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::04_Beta_Blockers #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::04_Beta_blockers #AK_Step2_v12::#UWorld::4780
#AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::06_Antihypertensives #PANCE::EOR::Family_med #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#UWorld::COMLEX::104180 #AK_Step2_v12::#UWorld::Step::19181 #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #PANCE::CARDIO::hypertension #AK_Step1_v12::#Bootcamp::Cardiology::23_Stable_Angina_and_Atherosclerosis::07_Anti-anginal_Therapy #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::05_Combined_Alpha-Beta_Blockers_(Carvedilol,Labetalol) #AK_Step1_v12::#UWorld::COMLEX::24475 #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::04_Beta-1_Selective_Beta_Blockers #AK_Step2_v12::#SketchyIM::01_Cardiology::01_Ischemic_Heart_Disease::09_Post_ACS_Management #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::16_Beta_Adrenergic_Antagonists #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::03_Antihypertensives_I #AK_Step1_v12::#UWorld::Step::1364 #AK_Step1_v12::#B&B::06_Cardio::04_Arrhythmias::01_Cardiac_Action_Potentials::Extra #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::04_Tachycardia::04_Narrow_Complex_Tachycardia:_AFib_&_AFlutter_Management #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::04_Beta-1_Selective_Blockers_(Atenolol,Esmolol,Metoprolol) #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::03_Bradycardia::02_Bradycardia_DDx #AK_Step2_v12::#SketchyIM::01_Cardiology::06_Blood_Pressure::02_Hypertension_Management #AK_Step1_v12::#B&B::06_Cardio::04_Arrhythmias::07_Antiarrhythmic_Drugs_II #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::18_Class_II_Antiarrhythmics #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::06_Non-selective_Beta-Blockers_(Propranolol,Timolol) #AK_Step2_v12::#AMBOSS::QFau3m #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::05_Retired_Lessons::03_Bradycardia::02_Bradycardia_DDx_and_SOAP #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::05_Antiarrhythmic_Drugs #AK_Step1_v12::#Bootcamp::Cardiology::10_Renin-Angiotensin-Aldosterone_System::02_Direct_Pharmacologic_Targets #AK_Step1_v12::#Low/HighYield::3-HighYield-temporary #AK_Step1_v12::#AMBOSS::7A04Oi #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::06_Drugs_for_Heart_Failure #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::04_Bradycardia #AK_Step2_v12::#SketchyIM::01_Cardiology::12_Retired_Lessons::01_Ischemic_Heart_Disease::03_Acute_Coronary_Syndromes_SOA_[OLD_VERSION] #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::01_Cardiology::01_Hemodynamics::06_Hypertension_Pharmacology #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::15_beta-blockers #PANCE::EOR::IM #AK_Step1_v12::#OME::04_Organ_Systems::01_Cardiology::01_Hemodynamics::06_Hypertension_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::09_Side_Effects_of_Beta_Blockers